Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 6
2017 1
2018 5
2019 7
2020 3
2021 5
2022 10
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.
Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Franke K, Schornagel K, Verkuijlen P, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, van der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK. Matlung HL, et al. Cell Rep. 2018 Jun 26;23(13):3946-3959.e6. doi: 10.1016/j.celrep.2018.05.082. Cell Rep. 2018. PMID: 29949776 Free article.
Evaluating new treatments for anaplastic thyroid cancer.
Coca-Pelaz A, Rodrigo JP, Lopez F, Shah JP, Silver CE, Al Ghuzlan A, Menke-van der Houven van Oordt CW, Smallridge RC, Shaha AR, Angelos P, Mendenhall WM, Piazza C, Olsen KD, Corry J, Tufano RP, Sanabria A, Nuyts S, Nathan CA, Vander Poorten V, Dias FL, Suarez C, Saba NF, de Graaf P, Williams MD, Rinaldo A, Ferlito A. Coca-Pelaz A, et al. Among authors: menke van der houven van oordt cw. Expert Rev Anticancer Ther. 2022 Nov;22(11):1239-1247. doi: 10.1080/14737140.2022.2139680. Epub 2022 Nov 9. Expert Rev Anticancer Ther. 2022. PMID: 36283091 Review.
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.
Iqbal R, Yaqub M, Bektas HO, Oprea-Lager DE, de Vries EGE, Glaudemans AWJM, Aftimos P, Gebhart G, Beelen AP, Schuit RC, Windhorst AD, Boellaard R, Menke-van der Houven van Oordt CW. Iqbal R, et al. Among authors: menke van der houven van oordt cw. Clin Cancer Res. 2023 Jun 1;29(11):2075-2084. doi: 10.1158/1078-0432.CCR-22-2720. Clin Cancer Res. 2023. PMID: 36735488
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles.
Rijcken CJF, De Lorenzi F, Biancacci I, Hanssen RGJM, Thewissen M, Hu Q, Atrafi F, Liskamp RMJ, Mathijssen RHJ, Miedema IHC, Menke-van der Houven van Oordt CW, van Dongen GAMS, Vugts DJ, Timmers M, Hennink WE, Lammers T. Rijcken CJF, et al. Among authors: menke van der houven van oordt cw. Adv Drug Deliv Rev. 2022 Dec;191:114613. doi: 10.1016/j.addr.2022.114613. Epub 2022 Nov 4. Adv Drug Deliv Rev. 2022. PMID: 36343757 Review.
Current state and upcoming opportunities for immunoPET biomarkers in lung cancer.
Slebe M, Pouw JEE, Hashemi SMS, Menke-van der Houven van Oordt CW, Yaqub MM, Bahce I. Slebe M, et al. Among authors: menke van der houven van oordt cw. Lung Cancer. 2022 Jul;169:84-93. doi: 10.1016/j.lungcan.2022.05.017. Epub 2022 May 31. Lung Cancer. 2022. PMID: 35679715 Free article. Review.
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Miedema IHC, Huisman MC, Zwezerijnen GJC, Grempler R, Pitarch AP, Thiele A, Hesse R, Elgadi M, Peltzer A, Vugts DJ, van Dongen GAMS, de Gruijl TD, Menke-van der Houven van Oordt CW, Bahce I. Miedema IHC, et al. Among authors: menke van der houven van oordt cw. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2068-2080. doi: 10.1007/s00259-023-06164-w. Epub 2023 Mar 2. Eur J Nucl Med Mol Imaging. 2023. PMID: 36859619 Free PMC article.
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.
Verhoeff SR, Oosting SF, Elias SG, van Es SC, Gerritse SL, Angus L, Heskamp S, Desar IME, Menke-van der Houven van Oordt CW, van der Veldt AAM, Arens AIJ, Brouwers AH, Eisses B, Mulders PFA, Hoekstra OS, Zwezerijnen GJC, van der Graaf WTA, Aarntzen EHJG, Oyen WJG, van Herpen CML. Verhoeff SR, et al. Among authors: menke van der houven van oordt cw. Clin Cancer Res. 2023 Feb 1;29(3):592-601. doi: 10.1158/1078-0432.CCR-22-0921. Clin Cancer Res. 2023. PMID: 36394882 Free PMC article.
52 results